VRDN
Viridian Therapeutics Inc
18.70$
+1.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +49.2% | +28.5% | -7.1% | +31.8% | -3.8% | -11.0% | -11.9% | -0.9% | +55.8% | -12.3% | +39.1% | |
| – | +50.2% | +28.8% | -7.2% | +31.9% | -3.8% | -11.0% | -11.9% | -1.2% | +56.4% | -12.2% | +37.8% | |
| – | -7.9% | -10.9% | +17.5% | +86.1% | -50.3% | +16.7% | +1.0% | +44.6% | +25.2% | -17.0% | -6.4% | |
| – | +52.5% | +28.5% | -6.8% | +31.8% | -4.7% | -11.3% | -11.5% | -12.9% | +78.2% | -12.9% | +28.8% | |
| – | +0.0% | +0.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.1% | -1.1% | +17.7% | +14.3% | +9.9% | -20.1% | +18.8% | +10.4% | +139.0% | -13.7% | +184.4% | |
| – | +14.6% | -1.9% | +40.7% | +12.5% | +15.7% | -29.6% | +55.9% | -3.6% | +39.5% | -26.7% | +23.1% | |
| – | +2.7% | -65.8% | +1,105.2% | -83.0% | -12.9% | +4.5% | +1,576.9% | -91.9% | +3.2% | -2.0% | -2.2% | |
| – | -40.1% | +19.5% | +17.3% | +101.8% | -66.2% | +81.3% | +119.2% | +18.1% | -13.7% | +53.3% | -35.0% | |
| – | +1.0% | +0.6% | -14.0% | +17.4% | +0.3% | +0.5% | -40.3% | +69.1% | +139.1% | +1.0% | +380.1% | |
| – | +55.9% | +31.8% | -9.1% | +33.7% | -5.1% | -10.0% | -14.8% | -2.4% | +43.6% | -11.9% | +4.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +13.8% | +23.0% | +4.5% | +4.0% | +20.5% | +1.6% | +0.3% | +0.2% | +3.7% | +20.5% | +5.5% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.